Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children
Camargo CA Jr
Published in Journal of Allergy and Clinical Immunology
Methodology
Randomized, double-blind, placebo-controlled trial of vitamin D3 1000 IU/day for 1 month in children with winter-related atopic dermatitis in Ulaanbaatar, with EASI severity as the primary outcome.
Key Findings
Vitamin D 1000 IU/day for one month significantly improved EASI scores for winter-related atopic dermatitis in Mongolian schoolchildren compared with placebo.
Conclusions
Vitamin D supplementation improved winter-related AD among Mongolian children, a population likely to have vitamin D deficiency in winter.
Limitations
Short one-month duration, modest sample (n=107), highly vitamin D-deficient winter population limiting generalisability, and no long-term or relapse follow-up.
Supplements Studied
Vitamin D supplementation improved winter-related AD among Mongolian children, a population likely to have vitamin D deficiency in winter.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.